|
FBXL4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64090963039598E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47597514607878E-12 |
| Normal-vs-Stage2 |
1.91704999999986E-05 |
| Normal-vs-Stage3 |
6.0107474553206E-13 |
| Normal-vs-Stage4 |
1.22699994609121E-09 |
| Stage1-vs-Stage2 |
4.128600E-01 |
| Stage1-vs-Stage3 |
1.820650E-01 |
| Stage1-vs-Stage4 |
2.911200E-01 |
| Stage2-vs-Stage3 |
9.104500E-02 |
| Stage2-vs-Stage4 |
1.420960E-01 |
| Stage3-vs-Stage4 |
9.545200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.43689570931383E-15 |
| Normal-vs-AfricanAmerican |
1.049450E-04 |
| Normal-vs-Asian |
7.28890000023519E-07 |
| Caucasian-vs-AfricanAmerican |
3.383600E-01 |
| Caucasian-vs-Asian |
2.972000E-01 |
| AfricanAmerican-vs-Asian |
8.731800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.52020626589911E-14 |
| Normal-vs-Female |
4.19109191795997E-12 |
| Male-vs-Female |
5.347500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.06569997271322E-09 |
| Normal-vs-Age(41-60Yrs) |
1.00131014590943E-12 |
| Normal-vs-Age(61-80Yrs) |
5.48427969704335E-12 |
| Normal-vs-Age(81-100Yrs) |
1.009350E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.281800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.543030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.602370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.169600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.339200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.183400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.667800E-01 |
| Classical-VS-Follicular |
6.771400E-01 |
| Classical-VS-Other |
3.496200E-01 |
| Classical-VS-Normal |
2.15316653395803E-12 |
| Tall-VS-Follicular |
5.836800E-01 |
| Tall-VS-Other |
6.076400E-01 |
| Tall-VS-Normal |
1.74840000255472E-08 |
| Follicular-VS-Other |
5.421600E-01 |
| Follicular-VS-Normal |
4.25499999678891E-08 |
| Other-VS-Normal |
1.243380E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.68798350034194E-13 |
| Normal-vs-N1 |
1.78879999701564E-09 |
| N0-vs-N1 |
4.548000E-01 |
|
|
